KAS
GH icon

Kestra Advisory Services’s Guardant Health GH Stock Holding History

Kestra Advisory Services’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-553
Closed -$56.5K – 3620
2025
Q4 		$56.5K Buy
+553
New +$49.5K ﹤0.01% 3851
2023
Q1 		– Sell
-11,491
Closed -$313K – 2167
2022
Q4 		$313K Sell
11,491
-898
-7% -$41.1K ﹤0.01% 1715
2022
Q3 		$667K Buy
12,389
+392
+3% +$20.1K 0.01% 1159
2022
Q2 		$484K Buy
11,997
+844
+8% +$41.8K 0.01% 1348
2022
Q1 		$739K Sell
11,153
-2,771
-20% -$190K 0.01% 1086
2021
Q4 		$1.39M Sell
13,924
-2,573
-16% -$266K 0.01% 840
2021
Q3 		$2.06M Sell
16,497
-1,298
-7% -$154K 0.02% 696
2021
Q2 		$2.21M Buy
17,795
+3,950
+29% +$531K 0.03% 613
2021
Q1 		$2.11M Buy
+13,845
New +$2.09M 0.03% 577

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kestra Advisory Services's GH Position: Q1 2026 in Review

Kestra Advisory Services sold out of Guardant Health (GH) in Q1 2026, closing a stake of 553 shares — an estimated $56.5K sold.

Kestra Advisory Services first reported a position in GH in Q1 2021 and held it in 9 quarters. The position peaked at $2.21M in Q2 2021. 485 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Kestra Advisory Services reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 553 Guardant Health shares in Q1 2026, an estimated $56.5K.
  • Kestra Advisory Services first reported a position in Guardant Health in Q1 2021 and held it in 9 quarters.
  • Kestra Advisory Services's Guardant Health position peaked at $2.21M in Q2 2021.
  • 485 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.